α-N-acetylgalactosaminidase from Clostridium perfringens
US7074605B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Jan 29, 2002 |
| Grant date | Jul 11, 2006 |
| Priority date | — |
| Expiry date | Jan 29, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y302/01049
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
An isolated and purified α-N-acetyl-D-galactosaminidase from Clostridium perfringens and homologs thereof are disclosed. A method for purifying and isolating the α-N-acetylgalactosaminidase from Clostridium perfringens by removing neuramidases is disclosed. A process for using the α-N-acetylgalactosaminidase from Clostridium perfringens in altering type A blood cells to type O blood cells is disclosed. A process for altering cells expressing blood group A epitope by using α-N-acetylgalactosaminidase isolated from Clostridium perfringens in altering the cells expressing blood group A epitope to cells expressing blood group O epitope is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.